Safety and immunogenicity of the quadrivalent human papillomavirus vaccine in patients with juvenile dermatomyositis: a real-world multicentre study

BACKGROUND: Concerns about the safety and efficacy of vaccines in patients with autoimmune diseases (AID) have led to contradictions and low vaccination coverage in this population, who are at a higher risk of infections, including by human papillomavirus (HPV). Although HPV vaccines have been recom...

Descripción completa

Detalles Bibliográficos
Autores principales: Grein, Ingrid Herta Rotstein, Pinto, Natalia Balera Ferreira, Groot, Noortje, Martins, Camila Bertini, Lobo, Aline, Aikawa, Nadia Emi, Barbosa, Cassia, Terreri, Maria Teresa, da Fraga, Aline Coelho Moreira, de Oliveira, Sheila Knupp Feitosa, Sztajnbok, Flavio, Paim Marques, Luciana B., Islabão, Aline Garcia, Appenzeller, Simone, Bica, Blanca, de Oliveira Sato, Juliana, Magalhães, Claudia Saad, Ferriani, Virgínia, Pasmans, Hella, Schepp, Rutger, van der Klis, Fiona, de Roock, Sytze, Wulffraat, Nico, Pileggi, Gecilmara Salviato
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7659057/
https://www.ncbi.nlm.nih.gov/pubmed/33176806
http://dx.doi.org/10.1186/s12969-020-00479-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7659057/
https://www.ncbi.nlm.nih.gov/pubmed/33176806
http://dx.doi.org/10.1186/s12969-020-00479-w

Ejemplares similares